Found 25 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies NA The purpose of this study is to determine disease-free survival, overall su...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
Apheresis of Patients With Immunodeficiency N/A Background:
\- Gene therapy is being investigated as a possible treatment ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial PHASE3 ASSIST I was the first randomized trial in patients with scleroderma to not...
Show More Location
Northwestern University
Learn More & Join Trial
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies PHASE1 Determine the safety and tolerability of POL6326 when used as a single mobi...
Show More Location
University of Kansas Cancer Center
Learn More & Join Trial
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor PHASE2 The purpose of this research study is:(1) to determine if high doses of che...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies PHASE2 To reduce the number of donors treated with IV AMD3100 who require a second...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors PHASE2 This study will gather information about the combination the drugs plerixaf...
Show More Location
Washington University School of Medicine
Learn More & Join Trial